Zapała, P.; Fus, Ł.; Lewandowski, Z.; Garbas, K.; Zapała, Ł.; Górnicka, B.; Radziszewski, P.
E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy. J. Clin. Med. 2021, 10, 5587.
https://doi.org/10.3390/jcm10235587
AMA Style
Zapała P, Fus Ł, Lewandowski Z, Garbas K, Zapała Ł, Górnicka B, Radziszewski P.
E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy. Journal of Clinical Medicine. 2021; 10(23):5587.
https://doi.org/10.3390/jcm10235587
Chicago/Turabian Style
Zapała, Piotr, Łukasz Fus, Zbigniew Lewandowski, Karolina Garbas, Łukasz Zapała, Barbara Górnicka, and Piotr Radziszewski.
2021. "E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy" Journal of Clinical Medicine 10, no. 23: 5587.
https://doi.org/10.3390/jcm10235587
APA Style
Zapała, P., Fus, Ł., Lewandowski, Z., Garbas, K., Zapała, Ł., Górnicka, B., & Radziszewski, P.
(2021). E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) Are Promising Immunohistochemical Markers of Selected Adverse Pathological Features in Patients Treated with Radical Prostatectomy. Journal of Clinical Medicine, 10(23), 5587.
https://doi.org/10.3390/jcm10235587
